Exeter Financial’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $908K | Sell |
11,607
-82
| -0.7% | -$6.62K | 0.35% | 62 |
|
|
2026
Q1 | $1.01M | Buy |
11,689
+1,446
| +14% | +$139K | 0.41% | 59 |
|
|
2025
Q4 | $984K | Buy |
10,243
+1,238
| +14% | +$120K | 0.42% | 59 |
|
|
2025
Q3 | $858K | Buy |
9,005
+82
| +0.9% | +$7.54K | 0.37% | 64 |
|
|
2025
Q2 | $778K | Sell |
8,923
-1,261
| -12% | -$107K | 0.35% | 65 |
|
|
2025
Q1 | $915K | Buy |
10,184
+285
| +3% | +$25.5K | 0.41% | 64 |
|
|
2024
Q4 | $791K | Buy |
9,899
+42
| +0.4% | +$3.64K | 0.36% | 64 |
|
|
2024
Q3 | $887K | Buy |
9,857
+186
| +2% | +$15.6K | 0.39% | 65 |
|
|
2024
Q2 | $761K | Buy |
9,671
+280
| +3% | +$23K | 0.36% | 65 |
|
|
2024
Q1 | $788K | Buy |
9,391
+2,222
| +31% | +$190K | 0.36% | 66 |
|
|
2023
Q4 | $621K | Sell |
7,169
-2,583
| -26% | -$197K | 0.3% | 66 |
|
|
2023
Q3 | $764K | Buy |
9,752
+580
| +6% | +$48.6K | 0.4% | 65 |
|
|
2023
Q2 | $801K | Sell |
9,172
-3,783
| -29% | -$326K | 0.41% | 66 |
|
|
2023
Q1 | $1.04M | Buy |
12,955
+3,392
| +35% | +$276K | 0.52% | 61 |
|
|
2022
Q4 | $743K | Sell |
9,563
-4,498
| -32% | -$365K | 0.39% | 61 |
|
|
2022
Q3 | $1.14M | Sell |
14,061
-115
| -0.8% | -$10.3K | 0.66% | 56 |
|
|
2022
Q2 | $1.27M | Buy |
14,176
+331
| +2% | +$33.5K | 0.71% | 54 |
|
|
2022
Q1 | $1.54M | Sell |
13,845
-205
| -1% | -$21.7K | 0.83% | 46 |
|
|
2021
Q4 | $1.48M | Sell |
14,050
-231
| -2% | -$26.7K | 0.81% | 47 |
|
|
2021
Q3 | $1.79M | Buy |
14,281
+216
| +2% | +$28K | 1.07% | 37 |
|
|
2021
Q2 | $1.78M | Buy |
14,065
+657
| +5% | +$82.5K | 1.03% | 37 |
|
|
2021
Q1 | $1.58M | Buy |
13,408
+342
| +3% | +$40.1K | 1% | 39 |
|
|
2020
Q4 | $1.53M | Buy |
13,066
+1,133
| +9% | +$125K | 1.06% | 39 |
|
|
2020
Q3 | $1.24M | Buy |
11,933
+40
| +0.3% | +$4.02K | 0.97% | 39 |
|
|
2020
Q2 | $1.09M | Sell |
11,893
-17
| -0.1% | -$1.63K | 0.91% | 43 |
|
|
2020
Q1 | $1.07M | Sell |
11,910
-300
| -2% | -$31.9K | 1.01% | 41 |
|
|
2019
Q4 | $1.39M | Sell |
12,210
-600
| -5% | -$65.8K | 1.07% | 41 |
|
|
2019
Q3 | $1.39M | Buy |
12,810
+82
| +0.6% | +$8.55K | 1.11% | 39 |
|
|
2019
Q2 | $1.24M | Sell |
12,728
-69
| -0.5% | -$6.3K | 1.04% | 42 |
|
|
2019
Q1 | $1.17M | Buy |
12,797
+59
| +0.5% | +$5.28K | 1.01% | 42 |
|
|
2018
Q4 | $1.16M | Hold |
12,738
| – | – | 1.09% | 40 |
|
|
2018
Q3 | $1.25M | Sell |
12,738
-86
| -0.7% | -$7.95K | 1.03% | 42 |
|
|
2018
Q2 | $1.1M | Sell |
12,824
-377
| -3% | -$31.5K | 0.97% | 43 |
|
|
2018
Q1 | $1.06M | Buy |
13,201
+2,231
| +20% | +$184K | 0.91% | 45 |
|
|
2017
Q4 | $886K | Buy |
+10,970
| New | +$879K | 0.77% | 50 |
|
Other funds holding MDT
FWIA
SRIM
DC
ECSS
CAI
VF
Exeter Financial's MDT Position: Q2 2026 in Review
Exeter Financial reduced its Medtronic (MDT) stake by 0.7% in Q2 2026, selling an estimated $6.62K and leaving 11,607 shares worth $908K. The position accounts for 0.35% of the portfolio, ranked #62.
Exeter Financial first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.79M in Q3 2021. 822 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Exeter Financial held 11,607 shares of Medtronic worth $908K as of Q2 2026.
- Exeter Financial sold 82 Medtronic shares in Q2 2026, an estimated $6.62K.
- Medtronic made up 0.35% of Exeter Financial's portfolio in Q2 2026, its #62 holding.
- Exeter Financial first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- Exeter Financial's Medtronic position peaked at $1.79M in Q3 2021.
- 822 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.